Skip to main content

Table 1 Cohort characteristics and malaria outcomes

From: Timing of in utero malaria exposure influences fetal CD4 T cell regulatory versus effector differentiation

Maternal characteristics n (%)
Total enrollees 166
Maternal age (mean) 22.1
Previous pregnancies (%)
 0 56 (33.7)
 1 51 (30.7)
 2 or more 59 (35.5)
Randomized chemoprevention arm
 Dihydroartemisinin-piperaquine 86 (51.8)
 Sulfadoxine-pyrimethamine 80 (48.2)
Malaria outcomes Positive n (%)
Assessments during pregnancy
 LAMPu at enrolment 89 (53.6)
 Any LAMP during monthly screening 81 (48.8)
Assessments at delivery
 Maternal peripheral blood
  Microscopy 4 (2.4)
  LAMP 20 (12.1)
Placental blood
 Microscopy 4 (2.4)
 LAMP 20 (12.1)
Cord blood
 Microscopy 0 (0)
 LAMP 3 (1.8)
Histopathology 63 (38.0)
 Parasites, pigment in monocytes ± fibrin 4 (2.4)
 Pigment only 59 (35.5)
Any malaria during pregnancy or delivery 131 (78.9)
Infant outcomes n (%)
Preterm (<37 weeks) 9 (5.4)
Low birth weight (<2500 g) 9 (5.4)
  1. uLoop-mediated isothermal amplification